The CDK Inhibitor, p27Kip1, Is Required for IL-4 Regulation of Astrocyte Proliferation

Journal of Immunology

Volumn 159, Issue 2, 1997, Pages 812-819

  Liu, Jinbo ^a   Flanagan, W Michael ^b   Drazba, Judith A ^a   Estes, Melinda L ^a   Barnett, Gene H ^a   Haqqi, Talat ^a   Kondo, Seiji ^a   Barna, Barbara P ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b GILEAD SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1B; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN RECEPTOR; LEUKOCYTE ANTIGEN; MICROTUBULE ASSOCIATED PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; ASTROCYTE; CELL CULTURE; CELL DIVISION; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANTIGENS, CD; ASTROCYTES; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; HUMANS; INTERLEUKIN-4; MICROTUBULE-ASSOCIATED PROTEINS; OLIGONUCLEOTIDES, ANTISENSE; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-4; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0031570868     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Howard, M., J. Farrar, M. Hilfiker, B. Johnson, K. Takatsu, T. Hamaoka, and W. E. Paul. 1982. Identification of a T cell-derived B cell growth factor distinct from interleukin 2. J. Exp. Med. 155:914.
2. MacGlashan, D., J. M. White, S. Huang, S. J. Ono, J. T. Schroeder, and L. M. Lichtenstein. 1994. Secretion of IL-4 from human basophils. J. Immunol. 152: 3006.
3. Bradding, P., I. H. Feather, P. H. Howarth, R. Mueller, J. A. Roberts, K. Britten, P. A. Bews, T. C. Hunt, Y. Okayama, C. H. Heusser, G. R. Bullock, M. K. Church, and S. T. Holgate. 1992. Interleukin-4 is localized to and released by human mast cells. J. Exp. Med. 176:1381.
4. Paul, W. E. 1991. Interleukin 4: a prototypic immunoregulatory lymphokine. Blood 77:1859.
5. Mitchell, LC., L. S. Davis, and P. E. Lipsky. 1989. Promotion of human T lymphocyte proliferation by IL-4. J. Immunol. 142:1548.
6. Toi, M., A. L. Harris, and R. Bicknell. 1991. Interleukin-4 is a potent mitogen for capillary endothelium. Biochem. Biophys. Res. Commun. 174:1287.
7. Suzamura, A., M. Sawada, Y. Itoh, and T. Marunouchi. 1994. Interleukin-4 induces proliferation and activation of microglia but suppresses their induction of class II major histocompatibility complex antigen expression. J. Neuroimmunol. 53:209.
8. Dechanet, J., J. Briolay, M. C. Rissoan, P. Chomarat, J. P. Calizzi, J. Banchereau, and P. Miossec. 1993. IL-4 inhibits growth factor-stimulated rheumatoid synoviocyte proliferation by blocking the early phases of the cell cycle. J. Immunol. 151:4908.
9. Topp, M. S., C. A. Papadimitriou, F. Eitelbach, M. Koenigsmann, E. Oelmann, B. Koehler, D. Oberberg, B. Reufi, H. Stein, E. Thiel, and W. E. Berdel. 1995. Recombinant human interleukin 4 has antiproliferative activity on human tumor cell lines derived from epithelial and nonepithelial histologies. Cancer Res. 55: 2173.
10. Toi, M., R. Bicknell, and A. L. Harris. 1992. Inhibition of colon and breast carcinoma cell growth by interleukin-4. Cancer Res. 52:275.
11. Obiri, N. J., G. G. Hillman, G. P. Haas, S. Sud, and R. K. Puri. 1993. Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4. J. Clin. Invest. 91:88.
12. Keegan, A. D., and J. H. Pierce. 1994. Interleukin 4 receptor: signal transduction by a hematopoietic receptor. J. Leukocyte Biol. 55:272.
13. 1 cell cycle progression in gastric carcinoma cells. Cancer Res. 54:1113.
14. Estes, M. L., K. Iwasaki, B. S. Jacobs, and B. P. Barna. 1993. Interleukin 4 down-regulates adult human astrocyte DNA synthesis and proliferation. Am. J. Pathol. 143:337.
15. Barna, B. P., M. L. Estes, J. Pettay, K. Iwasaki, P. Zhou, and G. H. Barnett. 1995. Human astrocyte growth regulation: interleukin-4 sensitivity and receptor expression. J. Neuroimmunol. 60:75.
16. Wesselingh, S. L., D. Levine, R. J. Fox, S. Choi, and D. E. Griffin. 1994. Intracerebral cytokine mRNA expression during fatal and nonfatal alphavirus encephalitis suggests a predominant type 2 T cell response. J. Immunol. 152:1289.
17. Woodroofe, M. N., and M. L. Cuzner. 1993. Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by nonradioactive in situ hybridization. Cytokine 5:583.
18. Kip1 for restriction point control of the fibroblast cell cycle. Science 272:877.
19. Flanagan, W. M., L. L. Su, and R. W. Wagner. 1996. Elucidation of gene function using C-5 propyne antisense oligonucleotides. Nat. Biotechnol. 14:1139.
20. Kip1 on resistance of tumor cells to anticancer agents. Nat. Med. 2:1204.
21. 1 cyclins. Cell 73:1059.
22. 1 cyclin-dependent kinases. Genes Dev. 9:1149.
23. 1-S phase protein kinase. Science 257:1958.
24. Rosenblatt, J. Y. Gu, and D. O. Morgan. 1992. Human cyclin-dependent kinase 2 is activated during the S and G2 phases of the cell cycle and associates with cyclin A. Proc. Natl. Acad. Sci. USA 89:2824.
25. 1 to S transition in mammalian cells. Oncogene 8:1593.
26. Gu, Y., J. Rosenblatt, and D. O. Morgan. 1992. Cell cycle regulation of CDK2 activity by phosphorylation of Thr 160 and Tyr 15. EMBO J. 11:3995.
27. Tassan, J. P., S. Schultz, J. Bartek, and E. A. Nigg. 1994. Cell cycle analysis of the activity, subcellular localization and subunit composition of human CAK (CDK-activating kinase). J. Cell Biol. 127:467.
28. Fesquet, D., J. C. Labbe, J. Derancourt, J. P. Capony, S. Galas, F. Girard, T. Lorca, J. Shuttleworth, M. Doree, and J. C. Cavadore. 1993. The MO15 gene encodes the catalytic subunit of a protein kinase that activates cdc2 and other cyclin-dependent kinases (CDKs) through phosphorylation of Thr161 and its homologues. EMBO J. 12:3111.
29. Fisher, R. P., and D. O. Morgan. 1994. A novel cyclin associates with MO15/ CDK7 to form the CDK-activating kinase. Cell 78:713.
30. Koff, A., and K. Polyak. 1995. p27KIP1, an inhibitor of cyclin-dependent kinases. Prog. Cell Cycle Res. 1:141.
31. Koff, A., F. Cross, A. Fisher, J. Schumacher, K. Leguellec, M. Philippe, and J. M. Roberts. 1991. Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell 66:1217.
32. 1-to -S transition. Mol. Cell. Biol. 15:3463.
33. Smith, E., B. Frenkel, R. Schlegel, A. Giordano, J. B. Lian, J. L. Stein, and G. S. Stein. 1995. Expression of cell cycle regulatory factors in differentiating osteoblasts: postproliferative up-regulation of cyclins B and E. Cancer Res. 55:5019.
34. Sgambato, A., E. K. Han, P. Zou, I. Schieren, and I. B. Weinstein. 1996. Overexpression of cyclin E in the HC11 mouse mammary epithelial cell line is associated with growth inhibition and increased expression of p27-kip1. Cancer Res. 56:1389.
35. 1 in mammalian fibroblasts. Science 259:1908.
36. 1 to S phase transition. Mol. Cell. Biol. 15:2612.
37. 1, in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta. Science 260:536.
38. Morgan, D. O. 1995. Cyclin-dependent kinases. Nature 374:131.
39. 1 phase arrest mediated by an inhibitor (p27-kip1) of cyclin-dependent kinase 4 activation. Cell 79:487.
40. Polyak, K., M. H. Lee, H. E. Bromage, A. Koff, J. M. Roberts, P. Tempst, and J. Massague. 1994. Cloning of p27-kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59.
41. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85: 707.
42. Kip1 accompany glial cell differentiation of central glia-4 cells. J. Biol. Chem. 272:442.
43. Kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells. Mol. Cell. Biol. 16:4327.
44. Hengst, L., and S. I. Ree. 1996. Translational control of p27-kip1 accumulation during the cell cycle. Science 271:1861.
45. Pagano, M., S. W. Tam, A. M. Theodoras, P. Beer-Romero, G. DelSal, V. Chau, P. R. Yew, G. F. Draetta, and M. Rolfe. 1995. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682.
46. Poon, R. Y. C., H. Toyoshima, and T. Hunter. 1995. Redistribution of the CDK inhibitor p27 between different cyclin-CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation. Mol. Biol. Cell 6:1197.
47. Soos, T. J., H. Kiyokawa, J. S. Yan, M. S. Rubin, A. Giordano, A. DeBlasio, S. Bottega, B. Wong, J. Mendelsohn, and A. Koff. 1996. Formation of p27-CDK complexes during the human mitotic cell cycle. Cell Growth Differ. 7:135.
48. Harper, J. W., S. J. Elledge, K. Keyomarsi, B. Dynlacht, L. Tsai, P. Zhang, S. Dobrowolski, C. Bai, L. Connell-Crowley, E. Swindell, M. P. Fox, and N. Wei. 1995. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6:387.
49. Zhang, H., G. Hannon, and D. Beach. 1994. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 8:1750.
50. Noda, A., Y. Ning, S. F. Venable, O. M. Pereira-Smith, and J. R. Smith. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression cloning screen. Exp. Cell Res. 211:90.
51. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817.
52. 1 arrest. Cell 76: 1013.
53. Halevy, O., B. Novitch, D. Spicer, S. Skapek, J. Rhee, G. Hannon, D. Beach, and A. Lasser. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018.
54. Reynisdottir, I., K. Polyak, A. Iavarone, and J. Massague. 1995. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev. 9:1831.